Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)

TPEX:4747 Revenue

Johnson Chemical Pharmaceutical Works had revenue of 138.19M TWD in the quarter ending June 30, 2025, a decrease of -8.12%. This brings the company's revenue in the last twelve months to 582.81M, down -5.44% year-over-year. In the year 2024, Johnson Chemical Pharmaceutical Works had annual revenue of 611.42M with 0.78% growth.

• Revenue (ttm): 582.81M
• Revenue Growth: -5.44%
• P/S Ratio: 5.17
• Revenue / Employee: 3.43M
• Employees: 171
• Market Cap: 3.01B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	611.42M	4.70M	0.78%
Dec 31, 2023	606.71M	112.04M	22.65%
Dec 31, 2022	494.67M	83.18M	20.21%
Dec 31, 2021	411.49M	-12.52M	-2.95%
Dec 31, 2020	424.02M	-1.32M	-0.31%